The consensus among analysts is that Cardiff Oncology, Inc. (CRDF) is a Buy stock at the moment, with a recommendation rating of 2. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 2 have rated it as a Hold, with 2 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is $0.

Cardiff Oncology, Inc. (NASDAQ:CRDF) trade information

Sporting 0.2% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Monday, Jun 29 when the CRDF stock price touched $5.75-1 or saw a rise of 11.65%. Year-to-date, Cardiff Oncology, Inc. shares have moved 309.68%, while the 5-day performance has seen it change 52.55%. Over the past 30 days, the shares of Cardiff Oncology, Inc. (NASDAQ:CRDF) have changed 105.67%. Short interest in the company has seen 313.17 Million shares shorted with days to cover at 0.35.

Cardiff Oncology, Inc. (CRDF) estimates and forecasts

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +44.8% over the past 5 years. Earnings growth for 2020 is a modest +66.2% while over the next 5 years, the company’s earnings are expected to increase by 0%.

Cardiff Oncology, Inc. (NASDAQ:CRDF)’s Major holders

Insiders own 0.19% of the company shares, while shares held by institutions stand at 11.4% with a share float percentage of 11.42%. Investors are also buoyed by the number of investors in a company, with Cardiff Oncology, Inc. having a total of 26 institutions that hold shares in the company. The top two institutional holders are Vanguard Group, Inc. (The) with over 270.78 Thousand shares worth more than $273.49 Thousand. As of March 30, 2020, Vanguard Group, Inc. (The) held 1.57% of shares outstanding.

The other major institutional holder is Renaissance Technologies, LLC, with the holding of over 139.71 Thousand shares as of March 30, 2020. The firm’s total holdings are worth over $141.11 Thousand and represent 0.81% of shares outstanding.

Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. As of March 30, 2020, the former fund manager holds about 1.26% shares in the company for having 216695 shares of worth $218.86 Thousand while later fund manager owns 53.99 Thousand shares of worth $54.53 Thousand as of March 30, 2020, which makes it owner of about 0.31% of company’s outstanding stock.